Call to scrap import tariffs on pharmaceuticals in global WTO talksBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7540.508-c (Published 02 March 2006) Cite this as: BMJ 2006;332:508
- John Zarocostas
The United States, Switzerland, and Singapore this week called for an end to import tariffs that affect trade in drugs and medical devices worth more than $56bn (£32bn; €47bn) a year. Products covered by the tariffs include pharmaceutical goods, from antibiotics to vitamins, and medical devices, from surgical equipment and instruments to x ray equipment, hearing aids, and orthopaedic appliances.
In a joint proposal, the countries said that scrapping the tariff would result in “effective action to improve access to medicines and medical devices needed to treat a wide variety of diseases effectively and ensure that these goods …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial